CRANBURY, N.J.--(BUSINESS WIRE)--CURE Media Group’s flagship product, CURE® magazine, the nation’s leading consumer digital and print media enterprise focusing on patients with cancer, is kicking off its first-ever social media takeover today, when Moving Mountains for Multiple Myeloma climber April Cooper controls the @curetoday Instagram feed.
“We are excited to launch the first-ever social media takeover for CURE®, said Michael J. Hennessy Jr, president of MJH Associates, parent company of CURE Media Group. This takeover will be a behind-the-scenes look, as she’ll be talking about her experience during her mother’s Multiple Myeloma journey, and sharing her climb through photos, videos and Instagram stories.”
Cooper, who is a resident of Dallas, Texas, will be climbing Mount Democrat in Colorado as part of the Multiple Myeloma Research Foundation’s Peak Weekend program and a Moving Mountains for Multiple Myeloma (MM4MM) initiative.
Follow Cooper on her weekend journey as she hikes the Rocky Mountains at 14,158 feet above sea level to honor her mother and to help raise awareness for multiple myeloma.
Follow CURE® on Instagram @curetoday, or follow #CURE or #MM4MM.
Patrick Dempsey Reflects on His Nonprofit, ‘General Hospital’ Star Talks Cancer and More
November 10th 2023From actor Patrick Dempsey saying that his late mother would be proud of his work at The Dempsey Center to a “General Hospital” actor discussing his cancer treatments, here’s what’s happening in the oncology space this week.
Read More
Survival May Not Differ by Race in Multiple Myeloma Treated With Abecma
November 6th 2023Researchers have found that, among patients with relapsed/refractory multiple myeloma who received treatment with the CAR-T cell therapy Abecma, race and ethnicity played roles in safety and response but not survival.
Read More
Patrick Dempsey Reflects on His Nonprofit, ‘General Hospital’ Star Talks Cancer and More
November 10th 2023From actor Patrick Dempsey saying that his late mother would be proud of his work at The Dempsey Center to a “General Hospital” actor discussing his cancer treatments, here’s what’s happening in the oncology space this week.
Read More
Survival May Not Differ by Race in Multiple Myeloma Treated With Abecma
November 6th 2023Researchers have found that, among patients with relapsed/refractory multiple myeloma who received treatment with the CAR-T cell therapy Abecma, race and ethnicity played roles in safety and response but not survival.
Read More
2 Clarke Drive
Cranbury, NJ 08512